{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T11:36:07Z","timestamp":1768044967226,"version":"3.49.0"},"reference-count":7,"publisher":"Japanese Society of Toxicology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2022]]},"DOI":"10.2131\/jts.47.193","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T22:09:48Z","timestamp":1651702188000},"page":"193-199","source":"Crossref","is-referenced-by-count":5,"title":["No obvious toxicological influences of 50 \u03bcL microsampling from rats administered phenacetin as a drug with hematological toxicity"],"prefix":"10.2131","volume":"47","author":[{"given":"Hirohiko","family":"Ohtsuka","sequence":"first","affiliation":[{"name":"Axcelead Drug Discovery Partners Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"LSIM Safety Institute Corporation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kitaura","sequence":"additional","affiliation":[{"name":"Axcelead Drug Discovery Partners Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kandori","sequence":"additional","affiliation":[{"name":"Axcelead Drug Discovery Partners Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Danbayashi","sequence":"additional","affiliation":[{"name":"Axcelead Drug Discovery Partners Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Axcelead Drug Discovery Partners Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Jinno","sequence":"additional","affiliation":[{"name":"Axcelead Drug Discovery Partners Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Nitta","sequence":"additional","affiliation":[{"name":"LSI Medience Co."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"Mori","sequence":"additional","affiliation":[{"name":"LSI Medience Co."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Iwai","sequence":"additional","affiliation":[{"name":"LSIM Safety Institute Corporation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Nakai","sequence":"additional","affiliation":[{"name":"LSIM Safety Institute Corporation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Saito","sequence":"additional","affiliation":[{"name":"National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[{"name":"National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Boelsterli, U.A., Shie, K.P., Br\u00e4ndle, E. and Zbinden, G. (1983): Toxicological screening models: drug-induced oxidative hemolysis. Toxicol. Lett., <b>15<\/b>, 153-158.","DOI":"10.1016\/0378-4274(83)90209-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Diehl, K.H., Hull, R., Morton, D., Pfister, R., Rabemampianina, Y., Smith, D., Vidal, J.M. and van de Vorstenbosch, C.; European Federation of Pharmaceutical Industries Association and European Centre for the Validation of Alternative Methods. (2001): A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol., <b>21<\/b>, 15-23.","DOI":"10.1002\/jat.727"},{"key":"3","unstructured":"ICH. (1994): ICH S3A: Note for guidance on toxicokinetics: The assessment of systematic exposure in toxicity studies. (https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Safety\/S3A\/Step4\/S3A_Guideline.pdf)"},{"key":"4","unstructured":"ICH. (2017): ICH S3A Q&amp;A focus on microsampling. (https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Safety\/S3A\/S3AIWG_Step4_2017_1116.pdf)."},{"key":"5","unstructured":"Robson, J.M. (1965): Toxic effects of aspirin and phenacetin. Practitioner, <b>194<\/b>, 85-89."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Whiterock, V.J., Morgan, D.G., Lentz, K.A., Orcutt, T.L. and Sinz, M.W. (2012): Phenacetin pharmacokinetics in CYP1A2-deficient beagle dogs. Drug Metab. Dispos., <b>40<\/b>, 228-231.","DOI":"10.1124\/dmd.111.041848"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Yokoyama, H., Hattori, N., Ohtsuka, H., Murata, E., Kobayashi, A., Muta, K., Takumi, A., Kitaura, H., Jinno, F., Iwai, A., Nakai, K., Mori, K., Saito, K. and Saito, Y. (2020): Lack of toxicological influences by microsampling (50 \u00b5L) from jugular vein of rats in a collaborative 28-day study. J. Toxicol. Sci., <b>45<\/b>, 319-325.","DOI":"10.2131\/jts.45.319"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/5\/47_193\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T05:08:39Z","timestamp":1651900119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/5\/47_193\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.47.193","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}